Equities analysts expect UnitedHealth Group Inc (NYSE:UNH) to announce $3.46 earnings per share for the current quarter, according to Zacks. Seven analysts have made estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $3.50 and the lowest is $3.40. UnitedHealth Group reported earnings per share of $3.14 in the same quarter last year, which would indicate a positive year-over-year growth rate of 10.2%. The company is scheduled to issue its next quarterly earnings results on Tuesday, July 16th.
According to Zacks, analysts expect that UnitedHealth Group will report full-year earnings of $14.70 per share for the current fiscal year, with EPS estimates ranging from $14.64 to $14.86. For the next fiscal year, analysts anticipate that the firm will post earnings of $16.64 per share, with EPS estimates ranging from $16.20 to $16.98. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. The business had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.04 earnings per share.
UNH has been the subject of a number of recent research reports. Credit Suisse Group reissued a “buy” rating and set a $310.00 price target on shares of UnitedHealth Group in a research note on Friday, February 8th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Raymond James lowered their target price on shares of UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating for the company in a research note on Wednesday, April 17th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $290.47.
UNH opened at $236.79 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. The company has a market cap of $224.36 billion, a P/E ratio of 18.38, a price-to-earnings-growth ratio of 1.26 and a beta of 0.74. UnitedHealth Group has a fifty-two week low of $208.07 and a fifty-two week high of $287.94.
In other UnitedHealth Group news, CEO David S. Wichmann bought 20,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 3rd. The stock was acquired at an average price of $231.79 per share, for a total transaction of $4,635,800.00. Following the completion of the acquisition, the chief executive officer now owns 904,367 shares of the company’s stock, valued at approximately $209,623,226.93. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $229.75, for a total transaction of $2,297,500.00. Following the transaction, the director now owns 187,663 shares of the company’s stock, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. Insiders have sold 27,930 shares of company stock valued at $6,746,683 in the last 90 days. 0.87% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Horizon Investments LLC lifted its stake in UnitedHealth Group by 138.4% in the first quarter. Horizon Investments LLC now owns 4,041 shares of the healthcare conglomerate’s stock valued at $999,000 after acquiring an additional 2,346 shares during the last quarter. Laurel Wealth Advisors Inc. lifted its stake in UnitedHealth Group by 20.0% in the first quarter. Laurel Wealth Advisors Inc. now owns 3,843 shares of the healthcare conglomerate’s stock valued at $950,000 after acquiring an additional 640 shares during the last quarter. WealthPLAN Partners LLC lifted its stake in UnitedHealth Group by 14.0% in the first quarter. WealthPLAN Partners LLC now owns 3,795 shares of the healthcare conglomerate’s stock valued at $896,000 after acquiring an additional 466 shares during the last quarter. Equitable Trust Co. lifted its stake in UnitedHealth Group by 20.6% in the first quarter. Equitable Trust Co. now owns 1,784 shares of the healthcare conglomerate’s stock valued at $441,000 after acquiring an additional 305 shares during the last quarter. Finally, BlueMountain Capital Management LLC raised its position in shares of UnitedHealth Group by 283.8% in the first quarter. BlueMountain Capital Management LLC now owns 6,390 shares of the healthcare conglomerate’s stock valued at $1,580,000 after purchasing an additional 4,725 shares during the period. Institutional investors and hedge funds own 87.29% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What Factors Can Affect Return on Equity?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.